1. [Liquid Biopsy in Multimodal Treatment of Esophageal Carcinoma].
- Author
-
Shimada H, Yajima S, Oshima Y, Nanami T, Suzuki T, and Otsuka S
- Subjects
- Biomarkers, Tumor blood, Biomarkers, Tumor genetics, Biopsy, Combined Modality Therapy, Esophageal Neoplasms blood, Esophageal Neoplasms genetics, Esophageal Neoplasms therapy, Humans, Mutation, Tumor Suppressor Protein p53 blood, Tumor Suppressor Protein p53 genetics, Esophageal Neoplasms pathology
- Abstract
Predicting and monitoring the treatment response of patients with esophageal carcinoma are important. Molecular analyses of biopsy specimens are useful; however, the characteristics of the biopsy specimen are not similar to those of whole tumors, including metastatic tumors. Therefore, liquid biopsy using blood samples has been applied for the prediction of the tumor stage, sensitivity to radiotherapy, sensitivity to chemotherapy, and recurrent disease. Liquid biopsy is advantageous for monitoring the treatment response and as an objective diagnostic tool; it is cost effective.
- Published
- 2015